WCM
PYXS icon

Winthrop Capital Management’s Pyxis Oncology PYXS Stock Holding History

Winthrop Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9K Hold
6,000
– – ﹤0.01% 242
2025
Q4 		$7K Hold
6,000
– – ﹤0.01% 248
2025
Q3 		$13K Hold
6,000
– – ﹤0.01% 217
2025
Q2 		$7K Hold
6,000
– – ﹤0.01% 234
2025
Q1 		$6K Hold
6,000
– – ﹤0.01% 218
2024
Q4 		$9K Buy
+6,000
New +$17.3K ﹤0.01% 223

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winthrop Capital Management's PYXS Position: Q1 2026 in Review

Winthrop Capital Management held its Pyxis Oncology (PYXS) position steady in Q1 2026 at 6,000 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #242.

Winthrop Capital Management first reported a position in PYXS in Q4 2024 and has held it in 6 quarters since. The position peaked at $13K in Q3 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Winthrop Capital Management held 6,000 shares of Pyxis Oncology worth $9K as of Q1 2026.
  • Winthrop Capital Management left its Pyxis Oncology share count unchanged in Q1 2026.
  • Pyxis Oncology made up ﹤0.01% of Winthrop Capital Management's portfolio in Q1 2026, its #242 holding.
  • Winthrop Capital Management first reported a position in Pyxis Oncology in Q4 2024 and has held it in 6 quarters since.
  • Winthrop Capital Management's Pyxis Oncology position peaked at $13K in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Winthrop Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.